← Eichor
Study identifier: NCT07666776 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Efficacy of Attention Bias Modification vs. Placebo for Social Anxiety Disorder

Condition: Social Anxiety Disorder (SAD) · Attention Bias Modification Treatment (ABMT) · Placebo Effect  ·  Sponsor: Tel Aviv University

PhaseNA
Planned participants90
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersNo

About this study

This study examines whether a computerized attention-training intervention called attention bias modification (ABM) can reduce symptoms of social anxiety disorder (SAD) in adults, and whether symptom improvement is specifically related to changes in attentional processing or to nonspecific factors such as expectancy and placebo effects.

This description comes directly from the study's public registry record.

Talk to the study team

Yair Bar-Haim, PhD  ·  97236405465  ·  yair1@tauex.tau.ac.il

Lital Kohn, MA  ·  97236405465  ·  litalkohn@tauex.tau.ac.il

Always discuss trial participation with your own doctor first.

Locations (1)

Tel Aviv universityTel Aviv, IsraelRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07666776